CCAAT/enhancer-binding protein δ (C/EBPδ) recently emerged as an essential player in the inflammatory response to bacterial infections. C/EBPδ levels increase rapidly after a proinflammatory stimulus, and increasing C/EBPδ levels seem to be indispensable for amplification of the inflammatory response. Here we aimed to elucidate the role of C/EBPδ in host defense in community-acquired pneumococcal pneumonia. We show that C/EBPδ 
INTRODUCTION
CCAAT/enhancer-binding protein δ (C/EBPδ) is a member of the C/EBP family of transcription factors. 1 Expression of C/EBPδ is typically low in most cell types but is rapidly induced by various extracellular stimuli, including IL-1, IL-6, LPS, and TNF-α. 2;3 Several in vitro studies have suggested that C/EBPδ is an important player in inflammation, especially during the acute-phase response. 2;4 Moreover, C/EBPδ expression levels seem to be associated with the magnitude of the inflammatory response toward LPS 5 , and C/EBPδ regulates COX-2 expression in different cell types. 6 Overall, these data suggest an important role for C/EBPδ during the acute-phase response in pulmonary infection.
In line with in vitro data, an important role of C/EBPδ in innate immunity has been established by showing that C/EBPδ plays a dual role during Escherichia (E.) coli-induced peritonitis. 7 Indeed, C/EBPδ -/-mice are resistant to transient infection with a low, nonlethal dose of E. coli but are highly susceptible to persistent infection with a higher, lethal, dose.
C/EBPδ contributes to protective immunity in persistent infection by amplifying the NF-κB-driven inflammatory response essential for bacterial elimination and survival. In contrast to the role of C/EBPδ in severe E. coli peritonitis, C/EBPδ -/-mice are protected against sterile inflammation. Indeed, C/EBPδ -/-mice demonstrated prolonged survival compared with wildtype mice in a double-hit LPS model for disseminated intravascular coagulation. 8 Moreover, C/EBPδ deficiency limits LPS-induced systemic inflammation, as reflected by reduced TNF-α and IL-6 levels. Therefore, C/EBPδ appears to be an essential component of the inflammatory response, although its exact role in infectious disease remains elusive and needs further exploration.
Here we aimed to further characterize the involvement of C/EBPδ during infectious disease. To this end, we subjected C/EBPδ -/-mice to a murine model of Streptococcus (S.) pneumoniae-induced pneumonia, a clinically relevant infection model. S. pneumoniae is the leading causative pathogen in community-acquired pneumonia, associated with high morbidity and mortality. 9 S. pneumoniae accounts for up to 36% of adult communityacquired pneumonia, and an estimated 570,000 cases of pneumococcal pneumonia occur annually, including 175,000 hospitalized cases and a fatality rate of 5-7%. 10 Worldwide S.
pneumoniae is responsible for an estimated 10 million deaths annually and causes more deaths than any other bacterial pathogen. 11 Given the high incidence of S. pneumoniae, further efforts to understand the host response mechanisms involved in pneumococcal pneumonia are of essential importance.
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Pneumococcal infections are initiated by asymptomatic colonization of the nasopharynx with subsequent dissemination into the lung, blood, and peripheral organs. To disseminate from the pulmonary compartment, S. pneumoniae binds to the platelet-activating factor receptor (PAFR) via cell wall phosphorylcholine (PC), after which the bacteria are endocytosed. 13 Subsequently, bacteria-containing vacuoles are directed away from lethal lysosomal trafficking toward transcytosis. 14 In line with an essential role of PAFR in pneumococcal transcytosis, PAFR -/-mice were found to be relatively resistant to pneumococcal pneumonia, as demonstrated by delayed and reduced mortality, diminished bacterial outgrowth, and reduced dissemination into the bloodstream. 15 Here we show that C/EBPδ deficiency prolongs survival, reduces bacterial dissemination, and limits the inflammatory response after pneumococcal pneumonia. Moreover, we
show that S. pneumoniae induces C/EBPδ expression levels in pulmonary epithelial cells, and that C/EBPδ subsequently induces PAFR expression. These findings suggest that C/ EBPδ aggravates pneumococcal-induced pneumonia by facilitating transcytosis in a PAFRdependent manner. Our data thus reveal a mechanism underlying the high mortality of pneumococcal infections and may potentially lead to the development of unique therapeutic modalities for the treatment of this severe infectious disease.
RESULTS
Pneumococcal Infection Induces C/EBPδ Expression. We first sought o determine c/ebpδ expression levels during experimental S. pneumoniae-induced pneumonia. To this end, wildtype mice were intranasally inoculated with 1 × 10 4 colony-forming units (CFU) and c/ebpδ mRNA levels were measured in lung tissue. C/ebpδ mRNA expression was low in uninfected lungs, whereas c/ebpδ levels were increased at 24 h and 48 h after S. pneumoniae inoculation (Fig. 1A) . In line with this finding, C/EBPδ protein levels also increased over time, as demonstrated by immunohistochemistry analysis (Fig. 1 B-D) . Interestingly, C/EBPδ was expressed mainly in bronchial epithelial and inflammatory cells in uninfected lungs, whereas C/EBPδ expression was significantly increased in both cell types after infection.
C/EBPδ Deficiency Improves Host Defense During S. pneumoniae-Induced Pulmonary
Infection. To define the biological role of C/EBPδ in pneumonia, we subjected wildtype and C/EBPδ -/-mice to experimental S. pneumoniae-induced pneumonia. wildtype mice began to die at 55 h after the intranasal inoculation of S. pneumoniae, and all mice succumbed within 86 h ( Fig. 2A) . C/EBPδ -/-mice began to die only after 64 h, and 1 of the 13 mice survived for longer than 120 h (the maximal observation time). Median survival was 62 h in the wildtype mice and 86 h in the C/EBPδ -/-mice. Notably, all wildtype mice had already succumbed due to infection at the median survival time of the C/EBPδ -/-mice. These findings suggest that C/EBPδ plays an essential detrimental role in S. pneumoniae pneumonia.
To substantiate our findings on the role of C/EBPδ in host defense against pneumococcal pneumonia, we next examined bacterial outgrowth in lungs. Bacterial loads were increased in the lungs of wildtype mice from ~3 × 10 4 at 6 h after inoculation to ~1 × 10 9 after 48 h (Fig. 2B ). Bacterial outgrowth in lungs of C/EBPδ -/-mice was similar to that in wildtype mice after 6 h and 24 h, whereas C/EBPδ -/-mice had a 50-fold lower bacterial load at 48 h postinoculation. Given that pneumonia is frequently complicated by systemic dissemination of the primary infection, we assessed bacterial outgrowth in blood as well. Bacterial dissemination was not observed at 6 h after inoculation, but significant dissemination was detected at 24 h and 48 h postinoculation in wildtype mice (Fig. 2C) . Interestingly, bacterial outgrowth was lower in C/EBPδ -/-mice than in wildtype mice. Strikingly, S. pneumoniae dis- -/-mice after intranasal inoculation with S. pneumoniae. Data are mean ± SEM (n = 7-8). *P < 0.05; **P < 0.01; ***P < 0.001. seminated into the bloodstream in all of the wildtype mice but in only 57% of the C/EBPδ -/-mice after 24 h and 50% of the C/EBPδ -/-mice after 48 h. The average bacterial load was significantly lower in these C/EBPδ -/-mice compared with the wildtype mice, however. In line with this finding, dissemination of S. pneumoniae to peripheral organs was observed at 24 h and 48 h after inoculation in both wildtype and C/EBPδ -/-mice, although to a lesser extent in the C/EBPδ -/-mice ( Fig. 2 D and E) . These results suggest that C/EBPδ aggravates S. pneumoniae-induced pulmonary infections and increases bacterial dissemination.
The widespread dissemination of bacteria suggests that the mice succumb to systemic disease leading to multiple organ failure; thus, we analyzed organ damage at 48 h postinoculation. Levels of the liver injury markers aspartate transaminase and alanine transaminase and the general tissue injury marker lactate dehydrogenase were strongly increased in the S. pneumoniae-infected wildtype mice, with significantly lower levels detected in the
C/EBPδ Deficiency Limits S. pneumoniae-Induced Inflammation. We next measured cytokine and chemokine levels in lung, blood, and peripheral organs. All cytokines/chemokines tested exhibited typically low expression at 6 h after inoculation, with increasing expression over time in both lung and plasma. IL-6 and MCP-1 levels increased to a similar extent in C/EBPδ -/-and wildtype mice by 24 h postinoculation in lung and plasma, whereas significantly reduced levels were observed in the C/EBPδ -/-mice at 48 h postinoculation ( Given that neutrophil recruitment to the site of infection is an important hallmark of host defense during pneumonia 16 , we next evaluated neutrophil influx in the lungs of wildtype and C/EBPδ -/-mice after inoculation with S. pneumoniae. The number of neutrophils increased over time to a similar extent in both wildtype and C/EBPδ -/-mice ( Fig. 3E ). In line with this finding, neutrophil content, as determined by myeloperoxidase level, was similar in both groups of mice (Fig. 3F ). These data show that C/EBPδ does not influence neutrophil influx during pneumococcal pneumonia.
On histopathologic examination, the lungs of wildtype mice exhibited confluent inflammation accompanied by pleuritis, bronchitis, edema, interstitial inflammation, and vasculitis. At 24 h after inoculation, the C/EBPδ -/-mice showed significantly more signs of bronchitis and slightly more (but not significantly so) signs of confluent inflammation ( Fig.   3G ), edema, and endothelialitis ( Fig. S3) , which resulted in a significantly higher histologi-
cal score compared with wildtype mice (Fig. 3H) . At 48 h after inoculation, all histological parameters were similar in wildtype and C/EBPδ -/-mice, although confluent inflammation was slightly lower in the C/EBPδ -/-mice ( Fig. 3G ). Overall, cytokine/chemokine levels are lower in C/EBPδ -/-mice compared with wildtype mice, but this has no affect on neutrophil influx and histopathological inflammation parameters. increased over time in the blood and lungs of both wildtype and C/EBPδ -/-mice to a similar extent, refuting our hypothesis that C/EBPδ would limit bacterial clearance in the systemic compartment ( Fig. 4 A and B) . Moreover, our data show that bacterial extravasation from blood into the lung is not affected by C/EBPδ. Thus, it is tempting to speculate that C/EBPδ specifically influences bacterial translocation from the lung into the blood.
Bacteria may cross the lung-blood barrier by directly inducing alveolar epithelial cell injury independent of leukocytes. 17 To assess the potential role of C/EBPδ in blood-lung barrier integrity associated with S. pneumoniae infection, we evaluated S. pneumoniaeinduced Evans blue (EB) dye leakage. 18 S. pneumoniae induced injury increased the permeability of the blood-lung barrier, as evidenced by increased EB dye levels in the lungs of infected mice (Fig. 4 C-F) . However, S. pneumoniae-induced leakage increased to similar extent in wildtype and C/EBPδ -/-mice, showing that C/EBPδ does not play a role in lung barrier protection in S. pneumoniae infection. Moreover, these data suggest that the observed difference in bacterial dissemination is caused by an alternative mechanism.
Along with disrupting the epithelial barrier, S. pneumoniae may bind to the PAFR or the Ig receptor (pIg-R) on epithelial cells, leading to intracellular uptake of bacteria and subsequent transcytosis. 15 To assess whether C/EBPδ could affect S. pneumoniae transcytosis, we determined pafr and pIg-R mRNA levels in the lung. Pafr mRNA levels increased over time, with high expression seen at 24 h and 48 h after S. pneumoniae inoculation in wildtype mice (Fig. 4G) . Pafr mRNA levels in C/EBPδ -/-mice also increased over time, although to lesser extent than in wildtype mice. pIg-R mRNA levels increased after S. pneumoniae inoculation, but with no differences between wildtype and C/EBPδ -/-mice (Fig.   S4A ). Strikingly, pafr mRNA levels positively correlated with bacterial dissemination of S. pneumoniae independent of the C/EBPδ genotype ( Fig. 4H and Fig. S4B ).
To confirm induction of PAFR expression during S. pneumoniae, we performed immunohistochemical analysis of pulmonary PAFR expression during the course of infection. PAFR expression was low in uninfected mice (Fig. 5 A and D) and increased significantly over time in epithelial cells of wildtype mice (Fig. 5 A-C) and only marginally in C/EBPδ -/-mice ( Fig. 5 D-F) . Overall, these data suggest that C/EBPδ-mediated PAFR expression is of pivotal importance for S. pneumoniae dissemination into the bloodstream. To further substantiate the importance of C/EBPδ to PAFR expression, we transfected cells with a PAFR promoter-driven luciferase construct. Stimulation with LTA or growth arrested S. pneumoniae-induced PAFR promoter activity (Fig. 6D ). In line with this finding, S. pneumoniae stimulation of airway epithelial Calu3 cells also induced both C/EBPδ and PAFR expression (Fig S5) .
C/EBPδ Enhances PAFR Expression Directly and on Stimulation with Lipoteichoic
NF-κB and C/EBPδ have been shown to act synergistically on different promoters 19 ; thus, we examined whether S. pneumoniae-induced PAFR luciferase activity would be affected by a specific NF-κB inhibitor. S. pneumoniae-induced PAFR expression was partly inhibited by BAY 11-7082, suggesting that C/EBPδ and NF-κB indeed synergistically drive PAFR expression during infection (Fig. 6E ). Interestingly however, C/EBPδ overexpression to higher levels than seen in our in vitro LTA or S. pneumoniae stimulations dramatically induced PAFR expression by itself (Fig. 6F) , demonstrating that C/EBPδ acts as direct transcriptional activator of the pafr gene. C/EBPδ thus regulates PAFR expression during S. pneumoniae
infection.
DISCUSSION
This study shows that C/EBPδ deficiency protects mice from S. pneumoniae-induced mortality. Our data demonstrate that C/EBPδ is highly induced during S. pneumoniae infection, and that it aggravates bacterial dissemination over the lung-blood barrier, leading to multiple organ failure and subsequent shorter overall survival. Of particular interest, we found that pulmonary PAFR levels are induced by S. pneumoniae in a C/EBPδ-dependent manner, and that PAFR levels are directly correlated with the amount of bacteria disseminated into the bloodstream. Moreover, we also found that C/EBPδ overexpression directly induces PAFR promoter activity in vitro. The potential importance of C/EBPδ-driven PAFR expression in pneumococcal pneumonia is in line with previous data showing that PAFR -/-mice are less likely to develop invasive disease and have more effective host defenses during pneumococcal pulmonary infection. 15 Remarkably, PAFR -/-mice exhibit a similar phenotype as C/EBPδ -/-mice, with reduced bacterial dissemination, diminished bacterial loads in the lung, and prolonged survival. Although these data support the idea that PAFR-mediated transcytosis is a prime mechanism through which pneumococci disseminate, bacteria do disseminate in the absence of PAFR, suggesting that S. pneumoniae-induced direct alveolar epithelial injury also contributes (at least in part) to S. pneumoniae-induced lethality.
C/EBPδ has been previously shown to be involved in the inflammatory response during persistent bacterial infection and has been suggested to act as an amplifier of the inflammatory response. 7 Indeed, C/EBPδ -/-mice were able to resist a transient peritoneal infection with low-dose E. coli, but were highly susceptible to persistent peritoneal infection with high-dose E. coli. At a first glance, our data showing that C/EBPδ plays an essential aggravating role in pneumococcal pneumonia seem to contradict these observations.
However, several important differences between our pneumonia model and the peritonitis model may explain this apparent discrepancy. Most notably, Gram-positive S. pneumoniae and Gram-negative E. coli express different pathogen-associated molecular patterns, of which PC might be the most important difference in this perspective. Indeed, PAFR-dependent transcytosis is facilitated by PC
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, and thus PC-negative E. coli will not disseminate in a PAFR-dependent manner. 20 However, the fact that host defenses against PC-positive
Pseudomonas aeruginosa are aggravated in PAFR -/-mice 21 suggests that an alternative mechanism may be responsible, at least in part. Another difference between our model and the foregoing model is in the site of primary infection, and it would be interesting to evaluate the role of PAFR in E. coli peritonitis. Independent of the actual mechanism, the role of C/EBPδ in innate immunity is not as straightforward as once expected, and C/EBPδ may play a detrimental role in antibacterial defense as well.
NF-κB and C/EBPδ have been shown to act synergistically on different promoters. 19 Moreover, PAFR is directly induced by NF-κB on TNF-α stimulation in MonoMac-1 cells 22 , whereas C/EBPδ also amplifies NF-κB-driven LPS-induced IL-6 levels. 7 Here we have shown that C/EBPδ regulates PAFR levels, and that S. pneumoniae-induced PAFR promoter activity is dependent in part on NF-κB. Thus, it seems that C/EBPδ and NF-κB act synergistically to regulate PAFR expression during infection. Interestingly however, C/EBPδ overexpression to higher levels than seen in our in vitro LTA or S. pneumoniae stimulations dramatically induced PAFR expression by itself, indicating that C/EBPδ may act as a direct transcriptional activator of the pafr gene under non physiological circumstances. Further experiments should aim to elucidate the exact interplay between C/EBPδ and NF-κB in PAFR regulation during infectious disease.
Our data shed light on previous experiments showing that PAFR -/-mice are protected against LTA-induced lung inflammation. 23 Those investigators proposed that LTA may be a ligand for PAFR or, alternatively, that LTA-TLR2-induced inflammation instigates the generation of endogenous mediators that serve as ligands for PAFR. However, our data suggest that LTA-dependent TLR2 activation induces PAFR expression in a C/EBPδ-dependent manner, and the lack of LTA-induced PAFR expression in PAFR -/-mice may actually explain the observed phenotype.
Considering that C/EBPδ has been shown to directly regulate proinflammatory cytokine expression 4;7
, we expected to find lower cytokine levels in the C/EBPδ -/-mice compared with the wildtype mice. Indeed, at 48 h after inoculation, IL-6, TNF-α, and MCP-1 levels were significantly lower in the absence of C/EBPδ in both lungs and peripheral organs;
however, at earlier time points, no difference in inflammatory response was observed between the different genotypes. Thus, we speculate that the observed differences in cytokine levels at 48 h are a mere reflection of the bacterial load and not related to the genotype of the mice. This supposition is in line with previous studies reporting that the extent of inflammation in this particular model closely follows the bacterial burden in the lungs 16;24 , and that pulmonary bacterial loads are strongly correlated with proinflammatory cytokine concentrations. 25 It is tempting to speculate that the suggested role of C/EBPδ in the induction of PAFR expression during S. pneumoniae infection may be part of a more general mechanism. In fact, the absence or antagonism of PAFR causes significant protection against bacterial translocation through intestinal epithelial cells 26 and influenza A-associated lethality 27 , PAFR contributes to cancer progression and metastasis 28 , and activation of PAFR plays a major role in the pathogenesis of experimental Dengue infection. 29 If C/EBPδ also induced PAFR levels in these disorders, it might be a potential target for therapeutic modulation.
Further study is needed to examine this provocative claim.
At a first glance, C/EBPδ-driven PAFR mediated bacterial dissemination may not seem to explain the observed reduced bacterial loads at the site of infection. However, it is well known that on dissemination, bacteria extravasate from the bloodstream into distant organs. Given that extravasation of S. pneumoniae to the lung on i.v. injection is not affected by C/EBPδ (Fig. 3B) , it is tempting to speculate that lower systemic bacterial loads will lead to reduced secondary infection of the lung, thereby causing reduced "local" bacterial loads.
Taken together, our data show that C/EBPδ plays a detrimental role in pneumococcal pneumonia-induced mortality. We suggest that C/EBPδ aggravates pneumococcal pneumonia by facilitating transcytosis in a PAFR-dependent manner. Overall, our findings make a substantial contribution to the understanding of the complex role of C/EBPδ in innate immunity.
MATERIALS AND METHODS
Mice. C/EBPδ -/-mice generated as described previously 30 and C57BL/6 mice (purchased from Charles River) were maintained at the animal facility of the Academic Medical Center only. At predefined time points after inoculation, organs were collected and homogenates prepared as described previously.
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Inflammatory Assays. TNF-α, IL-6, MCP-1, and IL-10 levels were determined using a cytometric bead array multiplex assay (BD Biosciences). KC and MIP-2 levels were measured by ELISA (R&D Systems). Myeloperoxidase was measured by ELISA (Hycult Biotechnology).
Histology. After embedding, lungs were stained with H&E to score inflammation, or tissue sections were stained for C/EBPδ and PAFR using immunohistochemical procedures, as described in SI Materials and Methods.
LightCycler Assay. LightCycler assays were performed on a LightCycler 480 Real-Time PCR system (Roche Diagnostics) using the primers listed in SI Materials and Methods.
Lung Permeability Assays. Lung permeability was assessed as described previously. Statistical Analysis. Differences between groups were analyzed using the Mann-Whitney U test. For the survival experiment, a Kaplan-Meier analysis was performed using the logrank test. Cell stimulations with C/EBPδ silencing constructs were analyzed by two-way ANOVA with Bonferroni correction. Analyses were performed using GraphPad Prism version 5.0. A P value < 0.05 was considered to indicate statistical significance. Figure S1 : wildtype mice succumb to systemic disease on Streptococcus pneumoniae-induced pneumonia. Levels of liver injury markers aspartate transaminase (ASAT) (A) and alanine transaminase (ALAT) (B) and general tissue injury marker lactate dehydrogenase LDH (C) in plasma of wildtype and C/EBPδ -/-mice at 48 h after intranasal inoculation of S. pneumoniae. 
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